Gil Mor came up in my research into CanTx vs Phenoxodial. http://medicine.yale.edu/news/article.aspx?id=6232
"We made the required breakthrough and now have a new generation of drugs that are thousands of times more powerful than the original drugs. But more importantly, we found that the changes we made now led to them killing cancer stem cells as well as the more prevalent somatic cancer cells," Kelly added.
"Chemotherapy is like cutting the grass," says Mor. "It doesn't kill the roots—the tumor-initiating cells. With this technology we can for the first time have a high degree of confidence in whether a drug is likely to be able to wipe out the full range of cancer cells within an ovarian cancer. And that is what we need to do in order to put patients into long-term if not permanent remission."
NRT Price at posting:
24.5¢ Sentiment: Buy Disclosure: Held
